ChemicalBook >> CAS DataBase List >>SNDX-5613
SNDX-5613
- CAS No.
- 2169919-21-3
- Chemical Name:
- SNDX-5613
- Synonyms
- SNDX-5613;Revumenib;SNDX-5613 SNDX5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
- CBNumber:
- CB47244410
- Molecular Formula:
- C32H47FN6O4S
- Molecular Weight:
- 630.82
- MDL Number:
- MFCD32701940
- MOL File:
- 2169919-21-3.mol
Last updated:2023-03-31 09:12:57
| Boiling point | 739.1±70.0 °C(Predicted) |
|---|---|
| Density | 1.28±0.1 g/cm3(Predicted) |
| solubility | DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM) |
| pka | 11.10±0.40(Predicted) |
| FDA UNII | LZ0M43NNF2 |
SNDX-5613 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0120274 | SNDX-5613 99.62% | 2169919-21-3 | 5mg | $500 | 2021-12-16 | Buy |
| ChemScene | CS-0120274 | SNDX-5613 99.62% | 2169919-21-3 | 10mg | $850 | 2021-12-16 | Buy |
| ChemScene | CS-0120274 | SNDX-5613 99.62% | 2169919-21-3 | 25mg | $1250 | 2021-12-16 | Buy |
| ChemScene | CS-0120274 | SNDX-5613 99.62% | 2169919-21-3 | 50mg | $1850 | 2021-12-16 | Buy |
| ChemScene | CS-0120274 | SNDX-5613 99.62% | 2169919-21-3 | 100mg | $2750 | 2021-12-16 | Buy |
SNDX-5613 Preparation Products And Raw materials
Raw materials
Preparation Products
SNDX-5613 Suppliers
Global( 40)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32480 | 60 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| Wuhan Nutra Biotechnology Co.,Ltd | +8617786394783 | nutrabiotech@outlook.com | China | 300 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
| Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
| Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8474 | 58 |
| Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
| Shanghai SuperLan Chemcial Technique Centre | 021-2022843681 15618226720 | chaolaichem@foxmail.com | China | 6870 | 58 |
| SINO High Goal Chemical Technology Co., Ltd. | 021-57646680 18306277365 | sunkai@chembiobanksh.com | China | 2048 | 55 |
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 | sales-cpd@caerulumpharma.com | China | 3421 | 58 |
2169919-21-3(SNDX-5613)Related Search:
SNS-062
PF-04929113
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide hydrochloride
N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea
SNDX-5613
acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid
Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
SNDX-5613 SNDX5613
Revumenib
2169919-21-3